Publications

Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the US.

Cramer, E; Ray, E; Lopez, V; Bracher, J; Brennen, A; Castro§Rivadeneira, A; Gerding, A; Gneiting, T; House, K; Huang, Y; Jayawardena, D; Kanji, A; Khandelwal, A; Le, K; Mühlemann, A; Niemi, J; Shah, A; Stark, A; Wang, Y; Wattanachit, N; Zorn, M; Gu, Y; Jain, S; Bannur, N; Deva, A; ... Adee, M.

2021

medRxiv (2021). 10.1101/2021.02.03.21250974.

Genomic reconstruction of the SARS-CoV-2 epidemic in England.

Vöhringer, HS; Sanderson, T; Sinnott, M; De Maio, N; Nguyen, T; Goater, R; Schwach, F; Harrison, I; Hellewell, J; Ariani, CV; Gonçalves, S; Jackson, DK; Johnston, I; Jung, AW; Saint, C; Sillitoe, J; Suciu, M; Goldman, N; Panovska-Griffiths, J; Wellcome Sanger Institute COVID-19 Surveillance Te,; COVID-19 Genomics UK (COG-UK) Consortium*,; Birney, E; Volz, E; FUNK, S; Kwiatkowski, D; ... Gerstung, M.

2021

NATURE, (2021).600 7889 10.1038/s41586-021-04069-y.

How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases.

Clark, J; Stolk, WA; Basáñez, M-G; Coffeng, LE; Cucunubá, ZM; Dixon, MA; Dyson, L; Hampson, K; MARKS, M; MEDLEY, GF; Pollington, TM; Prada, JM; Rock, KS; Salje, H; Toor, J; Hollingsworth, TD;

2021

Gates Open Research, (2021).5, 10.12688/gatesopenres.13327.1.

Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.

FU, H; Abbas, K; Klepac, P; VAN ZANDVOORT, K; Tanvir, H; Portnoy, A; JIT, M;

2021

medRxiv (2021). 10.1101/2021.05.28.21257964.

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.

AFOLABI, MO; ISHOLA, D; MANNO, D; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; Baiden, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; Gallagher, KE; Gaddah, A; ... EBL3001 study group,

2021

Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00128-6.

UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records.

Walker, JL; GRINT, DJ; STRONGMAN, H; EGGO, RM; Peppa, M; MINASSIAN, C; MANSFIELD, KE; RENTSCH, CT; DOUGLAS, IJ; MATHUR, R; WONG, AY S; Quint, JK; Andrews, N; Bernal, JL; SCOTT, JA; Ramsay, M; SMEETH, L; MCDONALD, HI;

2021

BMC public health, (2021).21 1 10.1186/s12889-021-10427-2.

Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study.

Portnoy, A; ABBAS, K; Sweet, S; Kim, JJ; JIT, M;

2021

BMJ Global Health, (2021).6 11 10.1136/bmjgh-2021-006940.

Behaviour, booster vaccines and waning immunity: modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era.

BARNARD, R; DAVIES, N; JIT, M; EDMUNDS, J; Centre for Mathematical Modelling of Infectious Di,;

2021

medRxiv (2021). 10.1101/2021.11.22.21266584.

cmmid/coronavirus_immunity.

Waterlow, NR; Van Leeuwen, E; DAVIES, N; FLASCHE, S; EGGO, RM;

2021

, Github (2021).

Date of introduction and epidemiologic patterns of SARS-CoV-2 in Mogadishu, Somalia: estimates from transmission modelling of 2020 excess mortality data.

KOLTAI, M; Warsame, A; Bashiir, F; Freemantle, T; Williams, C; JIT, M; Flasche, S; DAVIES, N; Aweis, A; Ahmed, M; Dalmar, A; Checchi, F; CMMID COVID-19 working group,;

2021

medRxiv (2021). 10.1101/2021.06.15.21258924.